Infant Bacterial Therapeutics AB (publ)

OM:IBT B Stock Report

Market Cap: SEK 763.8m

Infant Bacterial Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OM:IBT B Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Nov 24BuySEK 17,000Maria EkdahlIndividual500SEK 34.00
02 Sep 24BuySEK 350,000Anthon JahreskogIndividual14,000SEK 25.00
02 Sep 24BuySEK 25,500Maria EkdahlIndividual1,000SEK 25.50
28 May 24BuySEK 14,946Maria EkdahlIndividual156SEK 96.00
17 May 24BuySEK 26,207Anthon JahreskogIndividual270SEK 97.60

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IBT B?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders522,2253.88%
Private Companies1,873,43313.9%
General Public2,118,87715.7%
Institutions8,956,88566.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 84.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.3%
SIX Group AG, Asset Management Arm
1,515,579SEK 85.9m2.37%1.71%
11.1%
Northern Trust Global Investments
1,497,162SEK 84.9m33.5%no data
9.98%
Fourth Swedish National Pension Fund (AP4)
1,344,000SEK 76.2m0%0.03%
8.72%
Annwall & Rothschild Investments AB
1,174,634SEK 66.6m0%no data
5.19%
Lochnest Pty Ltd
698,799SEK 39.6m0%no data
4.94%
Keel Capital AB
666,053SEK 37.8m0%30.67%
4.6%
Premier Fund Managers Ltd.
619,991SEK 35.2m0%0.05%
4.47%
AMF Fonder AB
601,902SEK 34.1m0%0.01%
3.29%
SEB Investment Management AB
443,250SEK 25.1m0%0.01%
3.24%
Ålandsbanken Asset Management Ab
436,172SEK 24.7m6.62%5.36%
2.76%
Avanza Fonder AB
372,309SEK 21.1m98.3%0.02%
2.76%
Tredje AP-fonden
371,774SEK 21.1m0%0.01%
2.75%
David Dangoor
370,455SEK 21.0m0.75%no data
2.55%
IBG LLC, Asset Management Arm
343,432SEK 19.5m0%0.61%
2.31%
Pictet Asset Management Limited
311,169SEK 17.6m23.2%no data
1.81%
Nordnet AB (publ), Asset Management Arm
243,315SEK 13.8m16%0.19%
0.79%
Staffan Stromberg
106,910SEK 6.1m0%no data
0.57%
Handelsbanken Asset Management
76,687SEK 4.3m0%no data
0.35%
FCG Fonder AB
46,603SEK 2.6m0%0.03%
0.3%
Schroder Investment Management Limited
40,000SEK 2.3m0%no data
0.18%
Anthon Jahreskog
24,270SEK 1.4m0%no data
0.088%
Marathon Asset Management Limited
11,850SEK 671.9k-68.3%no data
0.083%
Anders Kronström
11,194SEK 634.7k0%no data
0.063%
Skandia Fonder AB
8,432SEK 478.1k0%no data
0.043%
Storebrand Fonder AB,
5,848SEK 331.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/13 03:59
End of Day Share Price 2025/05/13 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Infant Bacterial Therapeutics AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.